Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0140
0.00 (0.00%)
Feb 20, 2026, 4:00 PM EST
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $982.64 thousand as of February 24, 2026. Its market cap has decreased by -83.19% in one year.
Market Cap
982.64K
Enterprise Value
32.38M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 982.64K, a decrease of -99.72%. That is a compound annual growth rate of -58.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 982.64K | 18.35% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exousia Pro | 1.48M |
| Evofem Biosciences | 1.19M |
| International Stem Cell | 1.16M |
| CERo Therapeutics Holdings | 1.15M |
| Eastgate Biotech | 1.06M |
| Halberd | 1.05M |
| EV Biologics | 840.53K |
| Protagenic Therapeutics | 810.68K |